432 related articles for article (PubMed ID: 34648376)
1. Loss of Mitochondrial Ca
Bertero E; Nickel A; Kohlhaas M; Hohl M; Sequeira V; Brune C; Schwemmlein J; Abeßer M; Schuh K; Kutschka I; Carlein C; Münker K; Atighetchi S; Müller A; Kazakov A; Kappl R; von der Malsburg K; van der Laan M; Schiuma AF; Böhm M; Laufs U; Hoth M; Rehling P; Kuhn M; Dudek J; von der Malsburg A; Prates Roma L; Maack C
Circulation; 2021 Nov; 144(21):1694-1713. PubMed ID: 34648376
[TBL] [Abstract][Full Text] [Related]
2. Increased Reactive Oxygen Species-Mediated Ca
Liu X; Wang S; Guo X; Li Y; Ogurlu R; Lu F; Prondzynski M; de la Serna Buzon S; Ma Q; Zhang D; Wang G; Cotton J; Guo Y; Xiao L; Milan DJ; Xu Y; Schlame M; Bezzerides VJ; Pu WT
Circulation; 2021 May; 143(19):1894-1911. PubMed ID: 33793303
[TBL] [Abstract][Full Text] [Related]
3. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
[TBL] [Abstract][Full Text] [Related]
4. MCU overexpression evokes disparate dose-dependent effects on mito-ROS and spontaneous Ca
Hamilton S; Terentyeva R; Perger F; Hernández Orengo B; Martin B; Gorr MW; Belevych AE; Clements RT; Györke S; Terentyev D
Am J Physiol Heart Circ Physiol; 2021 Oct; 321(4):H615-H632. PubMed ID: 34415186
[TBL] [Abstract][Full Text] [Related]
5. Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathy.
Cole LK; Mejia EM; Sparagna GC; Vandel M; Xiang B; Han X; Dedousis N; Kaufman BA; Dolinsky VW; Hatch GM
J Mol Cell Cardiol; 2020 Jul; 144():24-34. PubMed ID: 32418915
[TBL] [Abstract][Full Text] [Related]
6. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
[TBL] [Abstract][Full Text] [Related]
7. Calcium Signaling and Reactive Oxygen Species in Mitochondria.
Bertero E; Maack C
Circ Res; 2018 May; 122(10):1460-1478. PubMed ID: 29748369
[TBL] [Abstract][Full Text] [Related]
8. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
[TBL] [Abstract][Full Text] [Related]
9. Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome.
Johnson JM; Ferrara PJ; Verkerke ARP; Coleman CB; Wentzler EJ; Neufer PD; Kew KA; de Castro Brás LE; Funai K
J Mol Cell Cardiol; 2018 Aug; 121():94-102. PubMed ID: 30008435
[TBL] [Abstract][Full Text] [Related]
10. Mechano-energetic aspects of Barth syndrome.
Dudek J; Maack C
J Inherit Metab Dis; 2022 Jan; 45(1):82-98. PubMed ID: 34423473
[TBL] [Abstract][Full Text] [Related]
11. SR Ca
Mustroph J; Wagemann O; Lebek S; Tarnowski D; Ackermann J; Drzymalski M; Pabel S; Schmid C; Wagner S; Sossalla S; Maier LS; Neef S
J Mol Cell Cardiol; 2018 Mar; 116():81-90. PubMed ID: 29410242
[TBL] [Abstract][Full Text] [Related]
12. Activation of the integrated stress response rewires cardiac metabolism in Barth syndrome.
Kutschka I; Bertero E; Wasmus C; Xiao K; Yang L; Chen X; Oshima Y; Fischer M; Erk M; Arslan B; Alhasan L; Grosser D; Ermer KJ; Nickel A; Kohlhaas M; Eberl H; Rebs S; Streckfuss-Bömeke K; Schmitz W; Rehling P; Thum T; Higuchi T; Rabinowitz J; Maack C; Dudek J
Basic Res Cardiol; 2023 Nov; 118(1):47. PubMed ID: 37930434
[TBL] [Abstract][Full Text] [Related]
13. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.
Sabbah HN
Heart Fail Rev; 2021 Mar; 26(2):237-253. PubMed ID: 33001359
[TBL] [Abstract][Full Text] [Related]
14. Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca
Bovo E; Mazurek SR; Zima AV
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1032-H1040. PubMed ID: 30028204
[TBL] [Abstract][Full Text] [Related]
15. Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.
Chatfield KC; Sparagna GC; Specht KS; Whitcomb LA; Omar AK; Miyamoto SD; Wolfe LM; Chicco AJ
J Inherit Metab Dis; 2022 Jan; 45(1):111-124. PubMed ID: 34821394
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria-derived ROS bursts disturb Ca²⁺ cycling and induce abnormal automaticity in guinea pig cardiomyocytes: a theoretical study.
Li Q; Su D; O'Rourke B; Pogwizd SM; Zhou L
Am J Physiol Heart Circ Physiol; 2015 Mar; 308(6):H623-36. PubMed ID: 25539710
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes.
He Q; Harris N; Ren J; Han X
Oxid Med Cell Longev; 2014; 2014():654198. PubMed ID: 25247053
[TBL] [Abstract][Full Text] [Related]
19. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
[TBL] [Abstract][Full Text] [Related]
20. Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H
Goncalves RLS; Schlame M; Bartelt A; Brand MD; Hotamışlıgil GS
FEBS Lett; 2021 Feb; 595(3):415-432. PubMed ID: 33112430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
